furosemide has been researched along with empagliflozin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angermann, CE; Biegus, J; Blatchford, JP; Brueckmann, M; Collins, SP; Ferreira, JP; Kosiborod, MN; Nassif, ME; Ponikowski, P; Psotka, MA; Salsali, A; Teerlink, JR; Tromp, J; Voors, AA | 1 |
| Damman, K; Horiuchi, Y; Hoshino, M; Kitai, T; Matsue, Y; Nitta, D; Nogi, K; Okumura, T; Onitsuka, K; Sato, S; Shibata, T; Voors, AA; Yoshida, K | 1 |
| Eppes, D; Halsey, E; Hobson, J; Kaur, A; Minchak, J; Patil, T | 1 |
2 trial(s) available for furosemide and empagliflozin
| Article | Year |
|---|---|
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Topics: Benzhydryl Compounds; Furosemide; Glucosides; Heart Failure; Humans | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Symporters; Treatment Outcome | 2023 |
1 other study(ies) available for furosemide and empagliflozin
| Article | Year |
|---|---|
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Glycated Hemoglobin; Heart Failure; Humans; Retrospective Studies; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Veterans | 2023 |